Arrowhead Pharmaceuticals

Yahoo Finance • last month

Arrowhead (ARWR) FQ1 2026 Revenue Hits $264M as REDEMPLO Approval Marks Commercial Shift

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) is one of the best multibagger stocks to invest in according to billionaires. On February 5, Arrowhead Pharmaceuticals achieved a strategic turning point in FQ1 2026, transitioning into a commer... Full story

Yahoo Finance • 2 months ago

Arrowhead price target lowered to $78 from $81 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Arrowhead (ARWR) to $78 from $81 and keeps an Equal Weight rating on the shares. Broad pipeline execution continues with multiple readouts expected later this year, including key Phase 3 SH... Full story

Yahoo Finance • 2 months ago

Arrowhead outlines pivotal 2026 milestones with REDEMPLO launch, $1.33B capital boost, and robust cardiometabolic pipeline

Earnings Call Insights: Arrowhead Pharmaceuticals (ARWR) Q1 2026 MANAGEMENT VIEW * Dr. Christopher Anzalone, Chairman, CEO & President, stated, "We had another quarter of strong execution across all areas of our business, and we are we... Full story

Yahoo Finance • 2 months ago

Arrowhead Pharmaceuticals Inc (ARWR) Q1 2026 Earnings Call Highlights: Strong Financial ...

This article first appeared on GuruFocus. Net Income: $30.8 million for the quarter ended December 31, 2025. Earnings Per Share (EPS): $0.22 per share based on 140.7 million fully diluted weighted average shares outstanding. Revenue: $264... Full story

Yahoo Finance • 2 months ago

Arrowhead Research: Fiscal Q1 Earnings Snapshot

PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Arrowhead Research Corp. (ARWR) on Thursday reported fiscal first-quarter net income of $30.8 million, after reporting a loss in the same period a year earlier. The Pasadena, California-base... Full story

Yahoo Finance • 2 months ago

Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600: S&P MidCap 400 constituent Ciena Corp. (NYSE: CIEN) will replace Dayforce Inc. (NYSE: DAY) in t... Full story

Yahoo Finance • 2 months ago

Arrowhead Stock Has Skyrocketed 290% in One Year, and One Fund Trimmed Its Holdings by $4 Million

Privium Fund Management reported a sale of 75,747 shares of Arrowhead Pharmaceuticals(NASDAQ:ARWR) in a February 2 SEC filing, with the estimated trade value at $3.71 million based on quarterly average pricing. What happened According to... Full story

Yahoo Finance • 4 months ago

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

PASADENA, Calif., December 15, 2025--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on December 12, 2025, the Company’s Board of Directors... Full story

Yahoo Finance • 4 months ago

Arrowhead Pharmaceuticals gets FDA Breakthrough Therapy status for plozasiran

[Omega 3 fatty acid molecules] piyaset/iStock via Getty Images * Arrowhead Pharmaceuticals, Inc. (ARWR [https://seekingalpha.com/symbol/ARWR]) has announced that the FDA has given Breakthrough Therapy designation to its investigational... Full story

Yahoo Finance • 5 months ago

How Do Sarepta (SRPT)’s Enhanced Safety Moves Reflect Its Approach to Long-Term Risk Management?

Earlier this week, Sarepta Therapeutics received FDA approval to begin dosing non-ambulant Duchenne muscular dystrophy patients in Cohort 8 of the ENDEAVOR study, evaluating an enhanced immunosuppression regimen with Elevidys, and announce... Full story

Yahoo Finance • 5 months ago

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index easing 0.1% PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 5 months ago

Stocks making the biggest moves midday: Dell, Arrowhead Pharmaceuticals, Urban Outfitters & more

Check out the companies making the biggest moves midday: Arrowhead Pharmaceuticals — The stock popped 19% after the biopharmaceutical company reported fiscal year revenue that beat analyst expectations. Arrowhead's top line for the period... Full story

Yahoo Finance • 5 months ago

Arrowhead Pharmaceuticals Inc (ARWR) Q4 2025 Earnings Call Highlights: FDA Approval and ...

This article first appeared on GuruFocus. Release Date: November 25, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)... Full story

Yahoo Finance • 5 months ago

Arrowhead outlines REDEMPLO expansion with $60,000 annual price and expects top-line SHASTA-3/4 data in Q3 2026

Earnings Call Insights: Arrowhead Pharmaceuticals (ARWR) Q4 2025 MANAGEMENT VIEW * Dr. Christopher Anzalone, CEO, announced Arrowhead’s first FDA approval for REDEMPLO, marking a major milestone as the company transitions to a commerci... Full story

Yahoo Finance • 5 months ago

Arrowhead Pharmaceuticals GAAP EPS of -$0.01 in-line, revenue of $829.45M beats by $72.01M

* Arrowhead Pharmaceuticals press release [https://seekingalpha.com/pr/20320479-arrowhead-pharmaceuticals-reports-2025-fiscal-year-end-results] (ARWR [https://seekingalpha.com/symbol/ARWR]): FY GAAP EPS of -$0.01 in-line. * Revenue of... Full story

Yahoo Finance • 5 months ago

After-Hours Earnings Report for November 25, 2025 : ADSK, WDAY, ZS, DELL, HPQ, NTAP, NTNX, ARWR, URBN, AMBA, CLSK, PD

The following companies are expected to report earnings after hours on 11/25/2025. Visit our Earnings Calendar for a full list of expected earnings releases. Autodesk, Inc. (ADSK)is reporting for the quarter ending October 31, 2025. Th... Full story

Yahoo Finance • 5 months ago

Here are the major earnings after the close Tuesday

Major earnings expected after the bell on Tuesday include: * Dell Technologies (DELL [https://seekingalpha.com/symbol/DELL]) * HP (HPQ [https://seekingalpha.com/symbol/HPQ]) * Zscaler (ZS [https://seekingalpha.com/symbol/ZS]) * Wo... Full story

Yahoo Finance • 5 months ago

Arrowhead Pharmaceuticals FQ4 2025 Earnings Preview

* Arrowhead Pharmaceuticals (ARWR [https://seekingalpha.com/symbol/ARWR]) is scheduled to announce FQ4 earnings results on Tuesday, November 25th, after market close. * The consensus EPS Estimate is -$0.16 [https://seekingalpha.com/sym... Full story

Yahoo Finance • 5 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index up 0.3% and the Heal PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 months ago

Arrowhead rises as FDA approves lead drug for rare disorder

[US Food and Drug Administration (FDA)] Shares of Arrowhead Pharmaceuticals (ARWR [https://seekingalpha.com/symbol/ARWR]) gained on Tuesday after the U.S. FDA approved its lead asset Redemplo (plozasiran) for adults with a rare genetic di... Full story